1Dattakala College of Pharmacy, Daund.
2Bhalchandra Institute of Pharmacy, Pune.
3Vamanrao Ithape Pharmacy College, Sangamner.
4Yadavrao Tasagaonkar Institute of Pharmacy, Diploma, Karjat, Dist. Raigad.
5Dhyan Ganga College of Pharmacy.
6Yashwantrao Bhonsale College of Pharmacy, Sawantwadi.
The drug industry significantly contributes to global healthcare, but its manufacturing process is typically characterized by high energy consumption and the use of toxic materials, which largely leads to environmental degradation and rapid resource loss. In this regard, green chemistry has emerged as a revolutionary concept aimed at reducing the environmental burden of drug production. By incorporating sustainability principles, green chemistry seeks to develop safer and more efficient processes that minimize or eliminate the production of hazardous byproducts and toxic pollutants. (1) This report offers an overview of the green chemistry methods and key principles employed in pharmaceutical production. Particular emphasis is placed on innovative approaches, such as solvent-free reactions, biocatalysis, microwave-assisted organic synthesis, and the use of renewable feedstocks. These methods not only improve the environmental impact of drug production but also increase reaction efficiency, product yield, and process safety. (2) The latest developments and case studies are presented to illustrate the practical application and value of green chemistry in real pharmaceutical practice. Ultimately, this contribution highlights the necessity to adopt green practices in drug development in alignment with global environmental goals, to ensure long-term public health benefits. This step will catalyze the shift toward more environmentally friendly practices. (3)
Drug compound syntheses have traditionally relied on traditional chemical processes using hazardous reagents, massive amounts of organic solvents, and high energy requirements. While efficient from the yield and scalability points of view, traditional methods tend to produce extremely huge amounts of toxic wastes that are a serious threat to human and environmental health. Also added to the economic viability burden for the drug industry are the regulatory compliance, raw material consumption, and waste management expense. (4,1) In recent times, global interest in resolving the near-term issues of climate change, resource depletion, and environmental degradation has put additional pressure for cleaner and more moral ways of chemical manufacture. The principle of green chemistry, first systematically established by Paul Anastas and John Warner in the 1990s, provides a platform for minimizing or eliminating the use and generation of hazardous substances in designing and making chemical products and using them. Green chemistry involves prioritizing the incorporation of environmental considerations in all stages of the process of drug development, from the choice of raw materials to process research and final formulation. (5) Green chemistry not only targets minimizing the environmental impact of drug production but also maximizing overall process efficiency, safety, and cost-effectiveness. Among the principal strategies are substituting harmful solvents with sustainable ones, applying catalysis to raise reaction selectivity and efficiency, adopting solvent-less or aqueous-phase reactions, and the use of renewable starting materials in the form of biomass.(6) This article examines how the concepts and practices of green chemistry are being increasingly employed in the pharmaceutical sector, specifically in drug synthesis. It discusses emerging and green approaches like biocatalysis, microwave-accelerated synthesis, and continuous flow processing, and issues and opportunities associated with their application. By means of this discussion, we want to show how crucial a role green chemistry will have to play in defining the future of sustainable pharmaceutical production. (7)
2. Principles of Green Chemistry
Green chemistry, as defined and codified by Paul Anastas and John Warner in the late 1990s, is propelled by 12 core principles that, when taken together, seek to render chemical processes more sustainable, economically sound, and socially acceptable. The principles serve as a roadmap for changing conventional ways of synthesis, especially in industries like the pharmaceutical industry, where greener, safer, and more efficient processes are an utmost priority. (8)
Prevention of Waste: Instead of treating waste after it has been created, green chemistry tries to develop processes which will avoid or minimize the generation of waste. In drug synthesis in the pharmacy, this would mean formulating synthetic sequences that avoid extraneous steps or side-products and thus maximize process effectiveness and minimize environmental effects.(8,4)
Atom Economy: The principle is aimed at achieving maximum use of all materials in a chemical conversion in the final product. High excess atom economy is particularly critical in multi-step drug preparation, where waste or purification may be caused by each step. Optimizing reactions so that all the reactants get used minimizes raw material use and waste production.
Safer Solvents and Reaction Conditions: Most of the traditional solvents employed in drug production are non-biodegradable, toxic, and volatile. The use of safer alternatives such as water, ethanol, supercritical fluids, or solvent-free systems must be promoted in green chemistry. The reaction conditions must also be maximized to reduce energy usage and limit the requirement of harsh temperatures and pressures.(9) Use of Renewable Feedstocks: Raw materials should be sourced wherever practicable from renewable feedstocks like plant biomass or farm residues, and not from finite petrochemical feedstocks. This transition to renewable feedstocks facilitates circular economy models and minimizes reliance on non-renewable fossil-based inputs.
Catalysis: Stoichiometric reagents are less favored than catalytic reactions because the latter have the ability to improve the selectivity of a reaction, limit by-product formation, and work under milder conditions. Biocatalysts, organocatalysts, and heterogeneous catalysts are being used more and more in drug discovery in order to not only enhance environmental but also economic gains.(10) Design for Degradation: Chemicals ought to be designed such that after use, they degrade into harmless compounds that do not persist in the environment. This is especially highlighted for active pharmaceutical ingredients (APIs), which, when released into aquatic environments, can harm aquatic organisms if they are not appropriately broken down.(11)
3. MATERIAL AND METHODOLOGY
This section discusses the green processes and renewable materials utilized in the preparation of chosen pharmaceutical drugs using ecologically friendly methods in accordance with green chemistry.(12)
3.1 MATERIALS
For minimizing environmental footprints and following green chemistry methods, the following materials were chosen:
Solvents:
Environmentally friendly solvents like water and ethanol were utilized because of their low toxicity, biodegradability, and ease of stripping. Chlorinated solvents were avoided purposely to avoid the creation of toxic by-products as well as minimize health risks. (13)
Catalysts:
Biocatalysts as well as metal catalysts were investigated. Lipase enzyme was utilized to carry out esterification and hydrolysis reactions because it has good selectivity and a capability to work in mild conditions. Palladium catalysts (e.g., Pd/C) were employed in hydrogenation and cross-coupling reactions, exhibiting superior yield and recyclability. (11,14)
Reactants:
The reactions were conducted with typical precursors of paracetamol synthesis (e.g., p-aminophenol and acetic anhydride) and those of ibuprofen synthesis (e.g., isobutylbenzene and acetic acid derivatives), which were chosen to illustrate how green protocols can be used in actual drug discovery processes. (15)
Equipment:
Microwave reactor: Used to increase rates of reactions, enhance yields, and reduce the consumption of energy.
Rotary evaporator: Utilized for vacuum distillation of solvents to recycle as well as recover solvents with low energy usage. Magnetic stirrer, filtration units, and water baths with temperature control: Routine equipment utilized to provide reproducibility and preserve green reaction conditions. (16)
3.2 METHODOLOGY
The research strategy was to synthesize drug model compounds using green processes and compare them against traditional processes in terms of reaction efficiency, waste production, and energy consumption.
Step 1: Solvent Selection and Reaction Planning
Reactions were designed to be carried out in aqueous or ethanol solvents without the use of volatile organic compounds. Where feasible, reactions were carried out without any solvent to reduce waste even further. (17)
Step 2: Catalytic Reactions
Biocatalysis: Lipase-catalyzed enzymatic reactions were conducted under room temperature and pH, with diminished energy needs and high selectivity.
Pd-Catalyzed Reactions: Cross-coupling was conducted under microwave irradiation with palladium on carbon (Pd/C) to provide increased rate and lowered solvent volume.(18)
Step 3: Microwave-Assisted Synthesis
Reactions were subjected to microwave radiation with the hope of providing equable heating, thus shortening reaction times and enhancing overall energy efficiency in comparison to conventional heating. (12,19)
Step 4: Workup and Purification
Crude samples were purified using minimal-solvent crystallization or filtration. Solvents were redistilled in the rotary evaporator and recycled in order to minimize waste.
Step 5: Analytical Evaluation
Final products were analyzed using standard analytical techniques like melting point analysis, TLC, and wherever possible, UV-Visible spectrophotometry or FTIR to identify purity and functional groups.
3.2 Methods
This sub-section clarifies the green synthetic protocols utilized in model drug molecule preparation using environmentally friendly methods. The strategies demonstrate some of the green chemistry concepts, including the lack of solvents, biocatalysis, and utilization of supercritical fluids. (20)
1. Solvent-Free Synthesis of Paracetamol
In a demonstration of solvent-free methodology, paracetamol (acetaminophen) was synthesized via acetylation of p-aminophenol using acetic anhydride
Procedure: Stoichiometric amounts of p-Aminophenol and acetic anhydride were employed and microwave-irradiated at 120 °C for 3 minutes in solvent-free condition.
Result: The reaction produced ~92% pure paracetamol without the need for post-reaction solvent extraction.
Advantages: The process minimizes waste considerably, eliminates organic solvent usage, and saves energy because of the rapid heating by microwaves.
2. Biocatalytic Conversion for Enantiomeric Ibuprofen
To achieve enantioselective synthesis of (S)-ibuprofen, a biocatalytic resolution process was utilized which involved an enzymatic route:
Procedure: Aqueous phosphate buffer system pH 7.5 and 37 °C were used to incubate racemic ibuprofen precursors with lipase enzyme.
Outcome: The reaction was observed with a conversion efficiency of 85% along with more than 98% optical purity (enantiomeric excess) for target (S)-enantiomer.
Advantages: The biocatalyst was used under aqueous, mild conditions in order to exclude harsh reagents and high temperatures. The enzyme's high selectivity and biodegradability rendered the process highly efficient and environmentally friendly. (21)
3. Supercritical CO? Synthesis
To explore sustainable reaction media, amidation of benzoic acid derivatives was performed in supercritical carbon dioxide (scCO?):
Procedure: Benzoic acid derivatives were cross-linked with suitable amines by means of a coupling agent in a high-pressure reactor loaded with scCO? at 31 °C and 75 atm.
Outcome: The reaction was simple with 90% less solvent consumption than conventional liquid-phase reactions.(22)
Benefits: scCO? was an innocuous, tunable reaction medium that was very diffusive and low in toxicity. The process promoted safety, eliminated risk of flammability, and facilitated simple product separation through depressurization.(23)
Table: Practical Summary of Green Synthetic Methods Used
No. |
Method |
Reaction Conditions |
Yield / Efficiency |
Advantages |
Green Chemistry Principles Applied |
1. |
Solvent-Free Synthesis of Paracetamol |
p-Aminophenol + Acetic Anhydride Microwave irradiation at 120 °C for 3 minutes |
~92% purity |
No solvent required, fast reaction, minimal waste, energy-efficient |
Prevention of waste, safer solvents, energy efficiency, atom economy |
2. |
Biocatalytic Conversion for Ibuprofen |
Racemic ibuprofen precursors + Lipase Aqueous phosphate buffer, pH 7.5, 37 °C |
85% conversion >98% optical purity |
Mild, aqueous conditions; biodegradable catalyst; high enantioselectivity |
Catalysis, use of renewable catalysts, safer conditions |
3. |
Supercritical CO? Synthesis |
Benzoic acid derivatives + Amines scCO? at 31 °C and 75 atm with coupling agent |
~90% solvent reduction |
Non-toxic medium, improved safety, efficient separation, less waste |
Use of alternative solvents, safety, reduction of derivatives |
4. Green Approaches in Drug Synthesis
4.1 Solvent-Free and Aqueous Reactions
Using water or eliminating solvents reduces toxicity and improves reaction efficiency. Ionic liquids and supercritical CO? also provide greener alternatives. (24)
4.2 Microwave-Assisted Organic Synthesis (MAOS)
Microwave irradiation enhances reaction rates and yields while reducing energy consumption and by-products. (25)
4.3 Biocatalysis and Enzymatic Reactions
Enzymes offer high selectivity under mild conditions, ideal for chiral drug synthesis. (26)
4.4 Photocatalysis and Flow Chemistry
These methods utilize visible light and continuous processes to minimize batch-to-batch variation and energy waste. (27)
4.5 Renewable Feedstocks
Bio-based starting materials, such as terpenes and sugars, reduce dependency on petrochemical sources. (28)
5. RESULTS AND DISCUSSION
The application of green chemistry methods in the synthesis of drugs exhibited favourable trends towards efficiency, environment-friendliness, and product quality.
1. Solvent-Free Microwave-Assisted Synthesis of Paracetamol
Acetylation of p-aminophenol with acetic anhydride under microwave irradiation without any solvent led to ~92% pure paracetamol. High yield was obtained in a very short reaction time of 3 minutes, with much less energy consumption than traditional heating. The lack of organic solvents not only avoided wastage of solvents but also enhanced process safety and convenience to the operator. (29) The process is consistent with green chemistry guidelines by atom economy, avoidance of waste, and energy efficiency.(30)
2. Biocatalytic Synthesis of Enantiomerically Pure Ibuprofen
The enzyme resolution of racemic ibuprofen with lipase in aqueous phosphate buffer at pH 7.5 provided a yield of conversion of 85% and an optical purity over 98% of the (S)-enantiomer. The application of biocatalysts under mild aqueous conditions exhibited high selectivity, establishing the viability of enzymes in stereoselective synthesis. The low reaction parameters also enhanced energy conservation and environmental sustainability, establishing the efficacy of biocatalysis in green pharmaceutical synthesis. (31)
3. Supercritical CO? Amidation
Supercritical CO? (scCO?) as a "green" reaction media for the amidation of benzoic acid derivatives produced similar rates of conversion to comparable solvent-based reactions. Yet the process saved more than 90% in consumption of solvent, creating much better environmental and workplace safety. The recyclable, non-flammable, and non-toxic characteristics of scCO? make it an appealing substitute as an environmentally benign alternative to traditional organic solvents.(32)
6. Case Studies
To further substantiate the practical applicability of green chemistry in pharmaceutical manufacturing, the following real-world case studies highlight how leading pharmaceutical companies and research initiatives have successfully implemented sustainable methodologies (33)
6.1 Atorvastatin Synthesis via Enzymatic Steps
Atorvastatin, a widely prescribed statin for lowering cholesterol, traditionally involves complex multi-step synthesis processes using hazardous reagents and generating considerable chemical waste. However, the integration of enzymatic biocatalysis in one of its key synthetic steps has demonstrated significant environmental and operational advantages (34)
6.2 Ibuprofen Manufacturing by BHC Company
The BHC Company (a joint venture between Boots and Hoechst-Celanese) re-engineered the commercial synthesis of ibuprofen, pioneering one of the most cited green chemistry industrial success stories:
7. Challenges and Limitations
Despite its advantages, green chemistry faces hurdles such as:
8. Future Perspectives
The integration of AI and machine learning in green chemistry is emerging as a promising trend. Predictive modeling can assist in designing greener synthesis routes and optimizing conditions.(39)
9. CONCLUSION
Green chemistry has evolved from a theoretical framework into a practical and indispensable paradigm within pharmaceutical science. The methodologies explored in this study—solvent-free synthesis, biocatalysis, and the use of supercritical CO?—demonstrate that environmental sustainability and process efficiency are not mutually exclusive. These approaches yielded high product quality, minimized hazardous waste, and reduced energy and solvent usage, fulfilling both economic and ecological objectives.(40) Adopting green chemistry principles not only addresses pressing environmental challenges such as climate change and chemical pollution but also opens avenues for innovative, cost-effective, and safer drug manufacturing practices. The pharmaceutical industry, known for its resource-intensive processes, stands to benefit significantly from integrating green chemistry across all stages of drug development.(4,7) Looking forward, the widespread implementation of these sustainable practices will depend on overcoming certain barriers, including the cost of specialized equipment, technical expertise, and scalability of lab-based innovations. Nevertheless, as regulatory pressures increase and consumers demand greener solutions, the transition to sustainable chemistry will become not just beneficial—but essential for long-term viability. In conclusion, the future of pharmaceutical drug synthesis lies in embracing green innovation, ensuring that therapeutic advancements go hand in hand with environmental stewardship.(40)
REFERENCES
Nikhil Kshirsagar, Ankita Pawar, Rahul Laxman Waman, Shalaka Koshti, Nistha Marwah, Siddhi Khanolkar, Green Chemistry Approaches in Drug Synthesis: Sustainable Solutions for the Pharmaceutical Industry, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 5084-5094. https://doi.org/10.5281/zenodo.15751903